Biom-71. Expanding The Spectrum Oftert Promoter Non-Canonical Sequence Variants In Cns Tumors: A Case Series
David Cook,Jorge Trejo-Lopez,Beth Pitel,Neiladri Saha,Tejaswi Koganti,Jayson Hardcastle,Stephanie Smoley,Matthew Isaacson,Mallika Gandham,Gopinath Sivasankaran,Surendra Dasari,Kar-Ming Fung,Suzanne Powell,Darshan Trivedi,Zied Abdullaev,Kenneth Aldape,Martha Quezado,Drew Pratt,P J Cimino,Mark Edgar,Rachael Vaubel,Aditya Raghunathan,Caterina Giannini,Robert Jenkins,Cristiane Ida
DOI: https://doi.org/10.1093/neuonc/noae165.0143
2024-11-29
Neuro-Oncology
Abstract:Most TERT promoter ( TERT p) clinically relevant sequence variants in CNS tumors are the canonical C228T and C250T mutations. Non-canonical TERT p mutations have been reported mainly in non-CNS tumors. We describe 12 CNS tumors with non-canonical TERT p variants interpreted as clinically relevant. Using clinical targeted NGS panels (2020-2024), we detected c.-100_-79dup (n=2), c.-92_-91insGGCGGCCCCGCCCCTTCCTTTC (n=1), c.-118_-117insTCCCCGGCCCAGCCCCTTCCGGG (n=1), c.-123_-76dup (n=1), c.-110_-89dup (n=2), and c.-57A>C (n=5). Most cases had chromosomal microarray (n=11) and/or methylation array data analyzed using the NCI/Bethesda v.2 classifier (n=9). All non-canonical TERT p variants occurred at a variant allele frequency suggestive of somatic clonal origin (mean, 34%; range, 18-46), and in adults (mean age, 60 years; range, 36-88). Except for the c.-57A>C variant, all non-canonical TERT p variants occurred in tumors with histological and/or molecular diagnostic features of glioblastoma, IDH-wildtype (GBM), often epigenetically aligning to this tumor type. All five tested cases matched to superfamily glioblastoma (score ≥ 0.9), with three to class GBM_RTK_I (>0.9 in 2, 0.86 in 1) and two to GBM_RTK_II (>0.9). The size and sequence of such variants suggest that these may be functionally equivalent to canonical mutations or generate favorable TERT p activation motif conformations like previously reported activating duplications. The c.-57A>C variant is a well-established oncogenic mutation observed in other cancer types but has not been reported in CNS tumors. We describe five cases with the c.-57A>C variant: one GBM matching to methylation class GBM_MES_TYP (0.99); two oligodendroglioma, IDH-mutant and 1p/19q-codeleted, one of which had methylation data matching to class O_IDH (0.99); one diffuse glioma, IDH-mutant, which was partially 1p/19q-codeleted and matched to class O_IDH (0.99); and one anaplastic meningioma, aligning to superfamily meningioma (0.99)/MNG_MAL (0.79). Our findings show that non-canonical TERT p variants typically occur in tumor types that often harbor TERT p canonical mutations, expanding the spectrum of TERT p clinically relevant variants that are molecular biomarkers in CNS tumors.
oncology,clinical neurology